INTUITIVE SURGICAL INC (ISRG)

434 -0.62 (-0.14%)

As of 2025-10-16 22:23:42 EST

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.

Traded asNasdaq: ISRG
ISINUS46120E6023
CIK0001035267
LEI54930052SRG011710797
EIN770416458
Sector—
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
CEODave Rosa
Employees15,638
Fiscal Year End1231
Address1020 KIFER ROAD, SUNNYVALE, CA, 94086
Phone4085232100
Websitehttp://intuitive.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
ISRGINTUITIVE SURGICAL INC2025-10-16 22:23:42434-0.62-0.14
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
ISRG0001035267INTUITIVE SURGICAL INCUS46120E602354930052SRG011710797770416458Nasdaq3842Orthopedic, Prosthetic & Surgical Appliances & Supplies1231DE1020 KIFER ROADSUNNYVALECA94086UNITED STATESUS40852321001020 KIFER ROAD, SUNNYVALE, CA, 940861020 KIFER ROAD, SUNNYVALE, CA, 94086——1995Dave Rosa15,638http://intuitive.com157,300,000,000358,400,000358,476,506Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.2025-10-10 19:04:11
This is a preview of the latest data. Subscribe to access the full data.
ISRG Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
ISRG Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024157,300,000,00037,700,000,00031.5217356,656,9644,331,1011.2293
2023119,600,000,00048,200,000,00067.507352,325,8631,936,1840.5526
202271,400,000,000-37,300,000,000-34.3146350,389,679-7,354,352-2.0558
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
David J. RosaPresident2023676,676—8,128,162860,12093,03812,563,956
Bob DesantisExecutive Vice President2023581,500—2,685,570622,56260,5094,838,192
Gary S. Guthart, Ph.D.Chief Executive Officer2023955,000—7,385,3071,610,74356,26712,449,381
Jamie E. SamathChief Financial Officer, Senior Vice President2023555,000—3,021,376386,27866,6925,028,365
Henry L. CharltonSenior Vice President2023580,000—3,021,376423,80772,3895,096,591
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202415,638
202313,676
202212,120
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue8,352,100,0007,124,100,0006,222,200,000
Cost Of Revenue2,717,900,0002,394,600,0002,026,200,000
Gross Profit5,634,200,0004,729,500,0004,196,000,000
Research And Development Expenses1,145,300,000998,800,000879,000,000
General And Administrative Expenses2,140,000,0001,963,900,0001,739,900,000
Operating Expenses3,285,300,0002,962,700,0002,618,900,000
Operating Income2,348,900,0001,766,800,0001,577,100,000
Net Income2,322,600,0001,798,000,0001,322,300,000
Earnings Per Share Basic6.545.123.72
Earnings Per Share Diluted6.425.033.65
Weighted Average Shares Outstanding Basic355,200,000351,200,000355,700,000
Weighted Average Shares Outstanding Diluted362,000,000357,400,000362,000,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents2,027,400,0002,750,100,0001,581,200,000
Marketable Securities Current1,985,900,0002,473,100,0002,536,700,000
Accounts Receivable1,225,400,0001,130,200,000942,100,000
Inventories1,487,200,0001,220,600,000893,200,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current7,111,000,0007,888,000,0006,253,000,000
Marketable Securities Non Current4,819,100,0002,120,000,0002,623,600,000
Property Plant And Equipment4,646,600,0003,537,600,0002,374,200,000
Other Assets Non Current———
Total Assets Non Current11,632,200,0007,553,500,0006,721,000,000
Total Assets18,743,200,00015,441,500,00012,974,000,000
Accounts Payable193,400,000188,700,000147,000,000
Deferred Revenue468,800,000446,100,000397,300,000
Short Term Debt———
Other Liabilities Current547,500,000587,500,000476,200,000
Total Liabilities Current1,745,300,0001,658,700,0001,422,100,000
Long Term Debt———
Other Liabilities Non Current———
Total Liabilities Non Current468,300,000385,500,000439,300,000
Total Liabilities2,213,600,0002,044,200,0001,861,400,000
Common Stock400,000400,000400,000
Retained Earnings6,803,300,0004,743,000,0003,500,100,000
Accumulated Other Comprehensive Income-51,300,000-12,200,000-162,500,000
Total Shareholders Equity16,433,700,00013,307,600,00011,041,900,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization439,000,000382,000,000326,000,000
Share Based Compensation Expense676,800,000592,800,000513,200,000
Other Non Cash Income Expense———
Change In Accounts Receivable95,900,000186,300,000159,300,000
Change In Inventories830,000,000712,500,000546,600,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable-400,00041,700,00021,300,000
Change In Other Liabilities108,300,000-32,900,000121,700,000
Cash From Operating Activities2,415,000,0001,813,800,0001,490,800,000
Purchases Of Marketable Securities5,139,600,0002,207,400,0001,399,500,000
Sales Of Marketable Securities100,200,000230,300,00061,100,000
Acquisition Of Property Plant And Equipment1,111,200,0001,064,200,000532,400,000
Acquisition Of Business1,000,0008,900,00012,800,000
Other Investing Activities———
Cash From Investing Activities-3,272,800,000-360,100,0001,370,800,000
Tax Withholding For Share Based Compensation270,000,000164,700,000194,200,000
Payments Of Dividends———
Issuance Of Common Stock429,400,000296,300,000233,800,000
Repurchase Of Common Stock0416,300,0002,607,400,000
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities315,000,000192,000,000234,000,000
Cash From Financing Activities150,900,000-287,600,000-2,572,300,000
Change In Cash-707,700,0001,169,400,000294,700,000
Cash At End Of Period2,027,400,0002,750,100,0001,581,200,000
Income Taxes Paid466,500,000447,800,000444,200,000
Interest Paid———
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share6.545.123.72
Price To Earnings Ratio79.810465.890671.3306
Earnings Growth Rate27.734437.6344-22.3382
Price Earnings To Growth Ratio2.87771.7508-3.1932
Book Value Per Share46.53638.147231.2415
Price To Book Ratio11.21638.84368.4935
Ebitda3,228,100,0002,627,800,0002,092,500,000
Enterprise Value———
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio———
Capital Expenditures1,548,000,0001,545,400,000823,800,000
Free Cash Flow867,000,000268,400,000667,000,000
Return On Equity0.14130.13510.1198
One Year Beta1.02231.20971.4001
Three Year Beta1.29681.34551.2467
Five Year Beta1.22721.25141.2782
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
LOEB GARYEVP & Chief Legal and Complian2025-10-102,612A4,857
LOEB GARYEVP & Chief Legal and Complian2025-10-101,296D3,561
LOEB GARYEVP & Chief Legal and Complian2025-10-102,612D2,612
Ladd Amy LDirector2025-09-04335D739
Ladd Amy LDirector2025-09-03336D1,074
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
James M InhofeSenator2019-05-20Sale (Full)2019-05-10Self$15,001 - $50,000
John F ReedSenator2019-03-18Sale (Full)2019-02-28Self$1,001 - $15,000
John F ReedSenator2019-03-01Sale (Full)2019-02-04Joint$1,001 - $15,000
James M InhofeSenator2018-11-08Purchase2018-10-25Self$15,001 - $50,000
John F ReedSenator2018-03-12Sale (Partial)2018-03-09Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Lisa McClain2025-08-13MI09Purchase2025-07-10Spouse$1,001 - $15,000
Lisa McClain2025-08-13MI09Sale2025-07-16Spouse$1,001 - $15,000
Lisa McClain2025-08-13MI09Sale (Partial)2025-06-09Spouse$1,001 - $15,000
Lisa McClain2025-08-13MI09Purchase2024-12-11Spouse$1,001 - $15,000
Jefferson Shreve2025-06-22IN06Sale2025-05-12—$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
WILLNER & HELLER, LLC2025-09-301,536,6823,436447.2299
Carnegie Investment Counsel2025-09-30320,664717447.2301
180 WEALTH ADVISORS, LLC2025-09-301,853,6344,145447.1976
OLIO Financial Planning2025-09-30525,4961,175447.2306
FULTON BREAKEFIELD BROENNIMAN LLC2025-09-30627,5541,403447.2944
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
CAPITAL MANAGEMENT INVESTMENT TRUST2025-08-31Institutional SharesWSACX2,2001,041,2491.66
CALAMOS INVESTMENT TRUST/IL2025-07-31Class ACAHEX6,9383,337,802.420.4452
Global X Funds2025-07-31Global X S&P 500 Covered Call & Growth ETFXYLG365175,597.850.3279
Global X Funds2025-07-31Global X S&P 500 Collar 95-110 ETFXCLR2311,065.070.3215
Global X Funds2025-07-31Global X S&P 500 Tail Risk ETFXTR136,254.170.3089
This is a preview of the latest data. Subscribe to access the full data.